These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10872667)

  • 1. Expression of DNA toposiomerase I and DNA topoisomerase II-alpha in testicular seminomas.
    Coleman LW; Perkins SL; Bronstein IB; Holden JA
    Hum Pathol; 2000 Jun; 31(6):728-33. PubMed ID: 10872667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
    Lynch BJ; Guinee DG; Holden JA
    Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
    Staley BE; Samowitz WS; Bronstein IB; Holden JA
    Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.
    Hafian H; Venteo L; Sukhanova A; Nabiev I; Lefevre B; Pluot M
    Hum Pathol; 2004 Jun; 35(6):745-51. PubMed ID: 15188142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
    Coleman LW; Bronstein IB; Holden JA
    Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical staining for DNA topoisomerase IIa in Hodgkin's disease.
    Brown MS; Holden JA; Rahn MP; Perkins SL
    Am J Clin Pathol; 1998 Jan; 109(1):39-44. PubMed ID: 9426516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
    Willman JH; Holden JA
    Prostate; 2000 Mar; 42(4):280-6. PubMed ID: 10679757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of DNA topoisomerase I, DNA topoisomerase II-alpha, and p53 in metastatic malignant melanoma.
    Lynch BJ; Komaromy-Hiller G; Bronstein IB; Holden JA
    Hum Pathol; 1998 Nov; 29(11):1240-5. PubMed ID: 9824101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase I and II expression in drug resistant germ cell tumours.
    Berney DM; Shamash J; Gaffney J; Jordan S; Oliver RT
    Br J Cancer; 2002 Sep; 87(6):624-9. PubMed ID: 12237772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining for DNA topoisomerase II in frozen and formalin-fixed paraffin-embedded human tissues.
    Holden JA; Snow GW; Perkins SL; Jolles CJ; Kjeldsberg CR
    Mod Pathol; 1994 Oct; 7(8):829-34. PubMed ID: 7838837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human deoxyribonucleic acid topoisomerases: molecular targets of anticancer drugs.
    Holden JA
    Ann Clin Lab Sci; 1997; 27(6):402-12. PubMed ID: 9433537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression.
    Monnin KA; Bronstein IB; Gaffney DK; Holden JA
    Hum Pathol; 1999 Apr; 30(4):384-91. PubMed ID: 10208458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DNA topoisomerase I in neoplasms of the kidney: correlation with histological grade, proliferation, and patient survival.
    Gupta D; Bronstein IB; Holden JA
    Hum Pathol; 2000 Feb; 31(2):214-9. PubMed ID: 10685636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human DNA topoisomerase I: An anticancer drug target present in human sarcomas.
    Coleman LW; Rohr LR; Bronstein IB; Holden JA
    Hum Pathol; 2002 Jun; 33(6):599-607. PubMed ID: 12152158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II alpha expression in testicular germ cell tumors.
    Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
    Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
    Suster S; Moran CA; Dominguez-Malagon H; Quevedo-Blanco P
    Hum Pathol; 1998 Jul; 29(7):737-42. PubMed ID: 9670832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
    Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
    Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
    Nakopoulou L; Lazaris AC; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
    Pathobiology; 2000; 68(3):137-43. PubMed ID: 11174071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.